Glucosamine for joint health: B → C
Large independent trials showed inconsistent benefit; grade lowered.
What we said before vs now
Before
Grade B
After
Grade C
small and inconsistent osteoarthritis benefit; large independent trials disappointed
What this does not change
- Interaction profile for Glucosamine — unchanged unless there is a separate severity change.
- Dose guidance — unchanged unless the new evidence altered the studied dose range.
- Safety recommendations — unchanged unless a safety event is recorded separately.
Reviewer & methodology
Reviewed and signed by Substrate editorial (Independent research collective) on . Methodology v1.
See also
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Glucosamine for joint health: B → C. https://evidencebased.info/changes/2026-03-01-glucosamine-joints-b-to-c. Updated 2026-03-01.
BibTeX
@misc{substrate_lucosaminejointsbtoc,
author = {Substrate editorial},
title = {Glucosamine for joint health: B → C},
year = {2026},
url = {https://evidencebased.info/changes/2026-03-01-glucosamine-joints-b-to-c},
note = {evidencebased.info}
}